(108 days)
No
The description focuses on RF energy delivery and user-controlled parameters, with no mention of AI or ML technologies.
Yes
The device is intended for the non-invasive treatment of mild to moderate facial wrinkles and rhytides, which constitutes a therapeutic purpose.
No
The device description indicates its purpose is for non-invasive treatment of facial wrinkles and rhytides using RF energy, not for diagnosing medical conditions.
No
The device description clearly outlines multiple hardware components including a main unit (console), touch screen user interface, RF power module controller unit, and three optional treatment applicators with RF electrodes. This indicates it is a hardware-based device with software control, not a software-only medical device.
Based on the provided information, the Venus Swan™ is not an In Vitro Diagnostic (IVD) device.
Here's why:
- Intended Use: The intended use is for "non-invasive treatment of mild to moderate facial wrinkles and rhytides" in dermatologic and general surgical procedures. This describes a therapeutic or aesthetic treatment applied directly to the patient's body, not a test performed on samples taken from the body.
- Device Description: The device uses Radiofrequency (RF) energy applied through applicators to the skin. This is a physical treatment modality, not a method for analyzing biological samples.
- Lack of IVD Characteristics: The description does not mention any components or processes related to collecting, preparing, or analyzing biological samples (like blood, urine, tissue, etc.) to provide diagnostic information.
IVD devices are specifically designed to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. The Venus Swan™ does not fit this description.
N/A
Intended Use / Indications for Use
The Venus Swan is a non-invasive device intended for use in Dermatologic and general surgical procedures for the non-invasive treatment of mild to moderate facial wrinkles and rhytides.
Product codes
GEI
Device Description
The Venus Swan™ System uses Radiofrequency (RF) energy in (MP)2 technology for treatment. (MP)2 technology is a Multi-Polar array of Bi-Polar RF electrodes.
The Venus Swan™ is a modification to the previously cleared Venus Concept's Venus Freeze system (K100586).
The Venus Swan™ is a non-invasive system consisting of:
- Main Unit (console) -
- Touch Screen user interface -
- RF Power module
- Controller unit
Three optional treatment applicators:
(1) Octipolar-LTM applicator - for large treatment areas, composed of 8 RF electrodes
(2) Octipolar-M™ applicator - for medium sized treatment areas, composed of 8 RF electrodes
(3) Diamondpolar™ applicator - for small treatment areas, composed of 4 RF electrodes
The system can be connected to two applicators only at a time. The user can choose which applicator to use according to the size of the treatment area.
The Touch screen user interface provides:
- Applicator selection -
- RF Power Output and Treatment Time parameter adjustments -
- Current treatment parameters display.
The RF power module provides RF energy to the selected applicator, producing a 1MHz signal.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
facial
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 878.4400 Electrosurgical cutting and coagulation device and accessories.
(a)
Identification. An electrosurgical cutting and coagulation device and accessories is a device intended to remove tissue and control bleeding by use of high-frequency electrical current.(b)
Classification. Class II.
0
OCT - 7 2011
Venuscollicept
510(K) SUMMARY
Venus Swan™ System 510(k) Number K | 784
Applicant's Name: Venus Concept Ltd. 62 HaHermesh Street Karmiel, 21652, Israel Tel: (972)3-644-6656 Fax: (972)3-644-6319
Yoram Levy, Qsite Contact Person: 31 Haavoda St. Binyamina, Israel 30500 Tel (972)4-638-8837; Fax (972)4-638-0510 Yoram@gsitemed.com
Venus Swan™M Trade Name:
Preparation Date: June 20, 2011
Classification: Name: Electrosurgical, cutting & coagulation device & accessories Product Code: GEI Regulation No: 21 CFR 878.4400 Class: II Panel: General and Plastic Surgery
Device Description:
The Venus Swan™ System uses Radiofrequency (RF) energy in (MP)2 technology for treatment. (MP)2 technology is a Multi-Polar array of Bi-Polar RF electrodes.
The Venus Swan™ is a modification to the previously cleared Venus Concept's Venus Freeze system (K100586).
The Venus Swan™ is a non-invasive system consisting of:
- Main Unit (console) -
- Touch Screen user interface -
- RF Power module
- Controller unit
Venus Swan - Special 510k Submission
2-2 ":
1
VENUSCOUCEP
Controller unit
Three optional treatment applicators:
(1) Octipolar-LTM applicator - for large treatment areas, composed of 8 RF electrodes
(2) Octipolar-M™ applicator - for medium sized treatment areas, composed of 8 RF electrodes
(3) Diamondpolar™ applicator - for small treatment areas, composed of 4 RF electrodes
The system can be connected to two applicators only at a time. The user can choose which applicator to use according to the size of the treatment area.
The Touch screen user interface provides:
- Applicator selection -
- RF Power Output and Treatment Time parameter adjustments -
- Current treatment parameters display.
Controller unit
Three optional treatment applicators
The RF power module provides RF energy to the selected applicator, producing a 1MHz signal.
Intended Use Statement:
The Venus Swan is a non-invasive device intended for use in Dermatologic and general surgical procedures for the non-invasive treatment of mild to moderate facial wrinkles and rhytides.
Substantial equivalence to the following predicate device is claimed: Predicate Devices:
| Device Name | 510k No. | Date of Clearance |
|---|---|---|
| Venus Freeze | K100586 | Nov 29, 2010 |
Performance Standards
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
: 1 : 1 : 1 :
Venus Swan complies with the following voluntary standards:
- EN 60601-1 (Medical Electrical Equipment-Part 1: General . Requirements for Safety-1. Collateral Standard: Safety Requirements for Medical Electrical Systems).
- IEC 60601-1-2 (Medical Electrical Equipment Part 1-2: Collateral . Standard: Electromagnetic Compatibility - Requirements and Tests)
- ANSI AAMI 60601-2-2 for safety of high frequency surgical equipment.
2-3
Venus Swan - Special 510k Submission
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" arranged around the perimeter. Inside the circle is a stylized symbol that resembles a bird or a person with outstretched arms, composed of three curved lines.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MID 20993-0002
Venus Concept Ltd. % Qsite Mr. Yoram Levy 31 Haavoda Street Binyamina, Israel 30500
- 7 2011
Re: K111784
Trade/Device Name: Venus Swan™ Regulation Number: 21 CFR 878.4400 Regulation Name: Electrosurgical cutting and coagulation device and accessories Regulatory Class: Class II Product Code: GEI Dated: August 22, 2011 Received: September 06, 2011
Dear Mr. Levy:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act
3
Page 2 - Mr. Yoram Levy
or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803): good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 331-542 of the Act): 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.hum for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
Mark N. Melkerson
Director Division of Surgical, Orthopedic and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Venuscollicept
INDICATIONS FOR USE STATEMENT
× 111784 510(k) Number (if known):
Device Name:
Venus Swan
Indications for Use:
The Venus Swan™ is a non-invasive device intended for use in Dermatologic and general surgical procedures for the non-invasive treatment of mild to moderate facial wrinkles and rhytides.
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
·- ·
(PLEASE DO NOT WRITE BELOW THIS LINE -CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign-off) Division of General, Restorative and Neurological Devices 510(k) Number
NufRP&d for mkm
(Division Sign-Off)
iston Sign-Off) Division of Surgical, Orthopedic, and Restorative Devices
510(k) Number K111784
Venus Swan .- Special 510k Submission
1-2